Dunhill Financial’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PPH
Dunhill Financial's PPH Position: Q3 2026 in Review
Dunhill Financial reduced its VanEck Pharmaceutical ETF (PPH) stake by 87% in Q3 2026, selling an estimated $78.5K and leaving 109 shares worth $43.7K. The position accounts for 0.01% of the portfolio, ranked #369.
Dunhill Financial first reported a position in PPH in Q2 2025 and has held it in 6 quarters since. The position peaked at $415K in Q4 2025. 156 funds tracked by Wall St. Rank hold PPH as of Q3 2026.
- Dunhill Financial held 109 shares of VanEck Pharmaceutical ETF worth $43.7K as of Q3 2026.
- Dunhill Financial sold 704 VanEck Pharmaceutical ETF shares in Q3 2026, an estimated $78.5K.
- VanEck Pharmaceutical ETF made up 0.01% of Dunhill Financial's portfolio in Q3 2026, its #369 holding.
- Dunhill Financial first reported a position in VanEck Pharmaceutical ETF in Q2 2025 and has held it in 6 quarters since.
- Dunhill Financial's VanEck Pharmaceutical ETF position peaked at $415K in Q4 2025.
- 156 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2026.
Based on Dunhill Financial's 13F filing for Q3 2026, filed 16 Nov 2026.